Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report

Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report

Abstract Background Osimertinib is a third-generation epidermal growth factor receptor (EGFR) inhibitor that is currently the first-line treatment for metastatic EGFR-mutated non-small-cell lung cancer (NSCLC) due to its favorable efficacy and tolerability profile compared to previous generations of...

Full description

Bibliographic Details
Main Authors: Karishma Patel, Kristie Y. Hsu, Kevin Lou, Krishan Soni, Yoo Jin Lee, Claire K. Mulvey, Alan H. Baik
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Cardio-Oncology
Subjects:
Osimertinib
Cardio-oncology
Cardiomyopathy
Pericardial effusion
Tamponade
Online Access:https://doi.org/10.1186/s40959-023-00190-1

Internet

https://doi.org/10.1186/s40959-023-00190-1

Similar Items